Maria Baile-Fuentes

Alicante, VC 03203, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Electrospun PMVEMA Nanofibers Developed as a Fast-Release Platform for Antineoplastic Drugs Tested in Glioblastoma Primary Cultures.

Electrospun PMVEMA Nanofibers Developed as a Fast-Release Platform for Antineoplastic Drugs Tested in Glioblastoma Primary Cultures.

Journal: Pharmaceutics
Published: July 07, 2025

Insights into histone deacetylase inhibitors-induced cell death in cancer cell lines.

Insights into histone deacetylase inhibitors-induced cell death in cancer cell lines.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 19, 2025

The intrinsically disordered, epigenetic factor RYBP binds to the citrullinating enzyme PADI4 in cancer cells.

The intrinsically disordered, epigenetic factor RYBP binds to the citrullinating enzyme PADI4 in cancer cells.

Journal: International journal of biological macromolecules
Published: April 05, 2023

Glioblastoma-Derived Small Extracellular Vesicles: Nanoparticles for Glioma Treatment.

Glioblastoma-Derived Small Extracellular Vesicles: Nanoparticles for Glioma Treatment.

Journal: International journal of molecular sciences
Published: March 09, 2023

New therapy for pancreatic cancer based on extracellular vesicles.

New therapy for pancreatic cancer based on extracellular vesicles.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 24, 2023

CLytA-DAAO Chimeric Enzyme Bound to Magnetic Nanoparticles. A New Therapeutical Approach for Cancer Patients?

CLytA-DAAO Chimeric Enzyme Bound to Magnetic Nanoparticles. A New Therapeutical Approach for Cancer Patients?

Journal: International journal of molecular sciences
Published: December 31, 2020

Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors BMS-754807 and OSI-906 on Human Cancer Cell Lines.

Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors BMS-754807 and OSI-906 on Human Cancer Cell Lines.

Journal: Cancers
Published: November 24, 2020

Cell Death Mechanisms Induced by CLytA-DAAO Chimeric Enzyme in Human Tumor Cell Lines.

Cell Death Mechanisms Induced by CLytA-DAAO Chimeric Enzyme in Human Tumor Cell Lines.

Journal: International journal of molecular sciences
Published: October 20, 2020

Main genetic differences in high-grade gliomas may present different MR imaging and MR spectroscopy correlates.

Main genetic differences in high-grade gliomas may present different MR imaging and MR spectroscopy correlates.

Journal: European radiology
Published: February 11, 2020

CLytA-DAAO, Free and Immobilized in Magnetic Nanoparticles, induces Cell Death in Human Cancer Cells.

CLytA-DAAO, Free and Immobilized in Magnetic Nanoparticles, induces Cell Death in Human Cancer Cells.

Journal: Biomolecules
Published: January 13, 2020

Correction: Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.

Correction: Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.

Journal: PloS one
Published: April 17, 2019

Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.

Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.

Journal: PloS one
Published: October 29, 2018
Showing 1-12 of 13

Last Updated: 09/26/2026